Some genetic disorders—such as cystic fibrosis, hemophilia and Tay Sachs disease—involve many mutations in a person’s genome, often with enough variation that even two individuals who share the same disorder might have a different combination of mutations. Complexities like these make it challenging to develop broadly applicable gene therapies for these disorders.
New gene-editing tech repurposes bacterial retrons to correct large stretches of DNA
